DGAP-Adhoc: PAION AG PLANS TO ISSUE UP TO 2.5 MILLION

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DGAP-Adhoc: PAION AG PLANS TO ISSUE UP TO 2.5 MILLION SHARES IN A PRIVATE PLACEMENT

PAION AG / Key word(s): Capital Increase 16.01.2014 01:54 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. AD-HOC ANNOUNCEMENT ACCORDING TO §15 WPHG PAION AG PLANS TO ISSUE UP TO 2.5 MILLION SHARES IN A PRIVATE PLACEMENT - U.S. institutional investor Capital Ventures International commits to immediately invest EUR 3.0 million with the option to subscribe for new shares resulting in proceeds up to a total amount of EUR 6.0 million in a private placement Aachen (Germany), 16 January 2014 - PAION AG (ISIN DE000A0B65S3; Frankfurt Stock Exchange General Standard: PA8) announced that the Company plans to issue in the coming weeks up to a total of 2,536,077 new shares in a private placement under exclusion of subscription rights of the shareholders. US institutional investor Capital Ventures International has the option to subscribe until 14 February 2014 for new shares resulting in proceeds up to a total amount of EUR 6.0 million in this private placement. As a new commitment and a first step Capital Ventures International has agreed today to immediately invest half of the amount of EUR 6.0 million, i.e. EUR 3.0 million. The price per share amounts to EUR 2.4079 calculated based on a daily volume weighted average share price (VWAP) over the last ten days before 15. January 2014 for PAION shares in XETRA trading on the Frankfurt Stock Exchange less a discount of 5%. Thus, Capital Ventures International will acquire 1.25 million shares in the first step. Furthermore, until 14 February 2014 Capital Ventures International has the right to buy shares up to the remaining proceeds of EUR 3.0 million. If Capital Ventures International invests less than a total of EUR 6 million, the company has the right to place the remaining shares with other investors. The potential total proceeds from the private placement of up to approximately EUR 6.0 million together with the gross issue proceeds of EUR 4.99 million from the rights offering will further improve PAION's financial leeway. The proceeds from the transaction will be used mainly for the preparation of the Remimazolam Phase III development program. Specifically it is intended to use the funds to produce the study medication and validate the production at market scale. ### About PAION PAION AG is a publicly-listed biotech company headquartered in Aachen, Germany with a second site in Cambridge, UK. The company has a track record in developing hospital-based treatments for which there is substantial unmet medical need. PAION AG is transforming its business model from a pure development company to a specialty pharmaceutical company with a focus on anaesthesia products to take advantage of the unique profile of its main compound, Remimazolam. Contact Ralf Penner Director Investor Relations / Public Relations PAION AG Martinstrasse 10-12 52062 Aachen - Germany Phone: +49 241 4453-152 E-mail: r.penner@paion.com www.paion.com Disclaimer: This release contains certain forward-looking statements concerning the future business of PAION AG. These forward-looking statements contained herein are based on the current expectations, estimates and projections of PAION AG's management as of the date of this release. They are subject to a number of assumptions and involve known and unknown risks, uncertainties and other factors. Should actual conditions differ from the Company's assumptions, actual results and actions may differ materially from any future results and developments expressed or implied by such forward-looking statements. Considering the risks, uncertainties and other factors involved, recipients should not rely unreasonably upon these forward-looking statements. PAION AG has no obligation to periodically update any such forward-looking statements to reflect future events or developments. This release does not constitute an offer of securities for sale or a solicitation of an offer to purchase securities of PAION AG in the United States or any other jurisdiction. Neither this announcement nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction. The securities of PAION AG may not be offered or sold in the United States absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended (the 'Securities Act'). The securities of PAION AG have not been, and will not be, registered under the Securities Act. 16.01.2014 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: PAION AG Martinstr. 10-12 52062 Aachen Germany Phone: +49 (0)241-4453-0 Fax: +49 (0)241-4453-100 E-mail: info@paion.com Internet: www.paion.com ISIN: DE000A0B65S3 WKN: A0B65S Listed: Regulierter Markt in Frankfurt (General Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Scroll down for more posts ▼

Top 10 Most Recent News Articles

HONOR X9e Pro Unveils with Massive Battery Power

Updated Category News Views 107

Lighting Up the Sky: HONOR's Big Move Picture this: the Burj Khalifa in Dubai, world’s tallest building, flashing with the promise of a smartphone's monstrous battery. That’s what the fine folks at HONOR did, highlighting their X9e Pro and its mind-boggling 11,000mAh battery. Now, am I the only one who finds it more than a little audacious to leverage such a flashy...

Continue Reading
Investor Scrutiny Intensifies Over M&A Deals at SGRY, RRC, EQT

Updated Category News Views 73

When Insiders Seem to Benefit More Ah, mergers and acquisitions—it's the oldest tango in the business world. But today, we've got some footwork that might trip up the small fry. Halper Sadeh LLC, the investor rights bulldogs, are sniffing around Surgery Partners, Range Resources, and EQT. Their quest? To uncover whether the big dogs are playing unfairly with...

Continue Reading
Honeywell Aerospace Faces Lawsuit After Stock Tumbles 23%

Updated Category News Views 0

Honeywell's Bumpy Ride Rattles Investors Something's brewing over at Honeywell Aerospace, Inc. (NASDAQ:HONA) and it's not your regular cup of joe. Investors, brace yourselves, because a securities fraud class action lawsuit is stacking up against them. With shares plummeting 23.16% in a whirlwind of a market day, it's kind of hard not to get a little riled up, isn't it?...

Continue Reading
EQS Group's Climate Goals Get SBTi Validation

Updated Category News Views 51

EQS Group's Bold Climate Commitments The news hits like a gust of clean air — EQS Group's climate targets are now stamped with the seal of approval from the Science Based Targets initiative (SBTi). This isn't just your typical corporate green pledge: we're talking serious, validated commitments pushing for net-zero emissions by 2050. Decoding EQS Group's Impactful...

Continue Reading
HCLTech Partners with Rapidus on Semiconductor Future

Updated Category News Views 116

Making Sense of the HCLTech and Rapidus Collaboration When you're talking about the world of semiconductors, no two words get tossed around more than innovation and speed. Now, with the recent partnership between HCLTech and Rapidus, those words are bound to echo from India to Japan and beyond. We have HCLTech, a stalwart of global technology, teaming up with Rapidus, a...

Continue Reading
Huntington Bank Bolsters Westside Future Fund with $1M Boost

Updated Category News Views 84

Huntington's Commitment Goes Beyond Dollars In a world where corporations often toss out pretty phrases without the substance to back them up, Huntington Bank's $1 million shout-out to Atlanta's Westside Future Fund (WFF) speaks volumes. This ain't your run-of-the-mill PR move. It's a solid, tangible effort to help a community that's rich in history but screaming for...

Continue Reading
EZRA Loop Fuses Human Insight and AI for Managers

Updated Category News Views 0

Hybrid Coaching: The Future is Here If someone told me five years ago that human coaches and AI would team up to churn out better business leaders, I'd have a laugh. But here we are with EZRA Loop, an inventive mix of flesh-and-blood wisdom and algorithmic precision hitting the streets. This might seem like the latest buzzword pie in the sky to some, but there's a real...

Continue Reading
SurgeONE's Avery Actions: Pioneering AI in Compliance

Updated Category News Views 102

Revolutionizing Compliance with Avery Actions A brand spanking new player has stepped onto the compliance stage, and it's swinging a pretty big AI bat. SurgeONE.ai unveiled Avery Actions, an industry-first agentic AI platform that's aiming to wrangle all your compliance, cybersecurity, and data governance operations under one interoperable umbrella. It's a bold move, and...

Continue Reading
Boar's Head Introduces Authentic Italian Ricotta

Updated Category News Views 28

Boar's Head Brings Verona's Ricotta Stateside Imagine walking into your kitchen and finding a slice of authentic Italy sitting right there on your counter. That's what Boar's Head promises with its introduction of Italian Ricotta All Natural Cheese. It’s not just cheese; it’s a culinary passport straight from Verona, Italy, crafted using traditional techniques that...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 172

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading

Top 5 Most Recently Viewed Articles

Equator Strengthens Offerings with New Key Partnerships

Updated Category News Views 125

Equator’s Expansion in the Real Estate Sector Equator, a prominent SaaS platform for real estate transaction management, recently broadened its customer base by incorporating four distinguished organizations into its network. This expansion includes notable names like Renovo Financial and HGF Management, showcasing Equator’s ongoing commitment to enhancing real estate...

Continue Reading
New Guidelines for Suppliers to Foster Sustainable Practices

Updated Category News Views 173

New Guidelines for Suppliers to Foster Sustainable Practices The Suppliers Partnership for the Environment (SP) is taking a significant step towards promoting sustainability in the automotive industry with the release of a new guidance document titled Advancing Sustainability in the Built Environment: New Building Recommendations for Suppliers. This publication aims to...

Continue Reading
Franklin Street Properties Announces New Quarterly Dividend

Updated Category News Views 151

Franklin Street Properties Corp. Dividend Announcement Franklin Street Properties Corp. (“FSP”, “our” or “we”) (NYSE American: FSP) has made an exciting announcement regarding its financial commitments. In a recent declaration from its Board of Directors, the company revealed that it would be issuing a quarterly dividend of $0.01 per share of common stock....

Continue Reading
Sarepta Therapeutics Unveils Updated Elevidys Safety Measures

Updated Category News Views 218

Sarepta Therapeutics' FDA Approval News Sarepta Therapeutics, Inc. (NASDAQ: SRPT) has experienced a significant uptick in its stock value after receiving essential updates concerning the Elevidys gene therapy. This follows a recent decision by the FDA to issue a new safety label that includes a Boxed Warning. This critical change illustrates the ongoing commitment of...

Continue Reading
PleoPharma Secures $36 Million for Cannabis Treatment Advancement

Updated Category News Views 163

PleoPharma Secures $36 Million for Cannabis Treatment Advancement Financing led by Biotech Specialist Funds with significant participation from Series A investors. Funding aimed at supporting the Phase 3 program for patients with Cannabis Use Disorder. PleoPharma, Inc., a dedicated organization focused on addressing cannabis-related health issues, has successfully closed...

Continue Reading